Mamoru Harada

Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia

Toshihiro Miyamoto, Koji Nagafuji, Koichi Akashi et al. · Blood · 1996 · 195 citations · Full text

Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo

Miki Tongu, Nanae Harashima, Hiroyuki Monma et al. · Cancer Immunology Immunotherapy · 2012 · 114 citations · Full text

Cancer Immunosurveillance, Oncology, Low-dose Cyclophosphamide +10

Anticancer Activity of ZnO Nanoparticles against Human Small-Cell Lung Cancer in an Orthotopic Mouse Model

Ryosuke Tanino, Yoshihiro Amano, Xuexia Tong et al. · Molecular Cancer Therapeutics · 2019 · 103 citations

Nanoparticles, Nanotherapeutics, Engineering +22

Prognostic impact of programmed cell death 1 ligand 1 expression in human leukocyte antigen class I-positive hepatocellular carcinoma after curative hepatectomy

Yuichiroh Umemoto, Shinji Okano, Yoshihiro Matsumoto et al. · Journal of Gastroenterology · 2014 · 90 citations

Prognostic Impact, Hepatology, Curative Hepatectomy +11

The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells

Min Zhang, Nanae Harashima, Tamami Moritani et al. · PLoS ONE · 2015 · 84 citations · Full text

Chemoprevention Strategy, Apoptosis, Cell Death +19